Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69

Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69

Abstract Due to the wide scale of inflammatory processes in different types of disease, more sensitive and specific biomarkers are required to improve prevention and treatment. Cluster of differentiation 69 (CD69) is one of the earliest cell surface proteins expressed by activated leukocytes. Here w...

Full description

Bibliographic Details
Main Authors:	Jonas Persson, Emmi Puuvuori, Bo Zhang, Irina Velikyan, Ola Åberg, Malin Müller, Per-Åke Nygren, Stefan Ståhl, Olle Korsgren, Olof Eriksson, John Löfblom
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-09-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-97694-6

Similar Items

DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells
by: Pierre Cheung, et al.
Published: (2025-01-01)

Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β
by: Olivia Wegrzyniak, et al.
Published: (2023-09-01)

Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells
by: Pierre Cheung, et al.
Published: (2023-12-01)

An anti-sortilin affibody-peptide fusion inhibits sortilin-mediated progranulin degradation
by: Moira Ek, et al.
Published: (2024-08-01)

Non-invasive PET imaging of liver fibrogenesis using a RESCA-conjugated Affibody molecule
by: Olivia Wegrzyniak, et al.
Published: (2024-05-01)

Optimized method for fluorine-18 radiolabeling of Affibody molecules using RESCA
by: Francesco Lechi, et al.
Published: (2024-10-01)

Potential of [11C]UCB-J as a PET tracer for islets of Langerhans
by: Emmi Puuvuori, et al.
Published: (2021-12-01)

Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor
by: Linnea Charlotta Hjelm, et al.
Published: (2023-07-01)

PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE
by: Emmi Puuvuori, et al.
Published: (2022-04-01)

Cellular effects of HER3-specific affibody molecules.
by: Lovisa Göstring, et al.
Published: (2012-01-01)

PET Imaging of GPR44 by Antagonist [<sup>11</sup>C]MK-7246 in Pigs
by: Pierre Cheung, et al.
Published: (2021-04-01)

Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution
by: Haozhong Ding, et al.
Published: (2021-03-01)

Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
by: Tianqi Xu, et al.
Published: (2022-02-01)

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model
by: Charles Dahlsson Leitao, et al.
Published: (2020-06-01)

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
by: Javad Garousi, et al.
Published: (2017-07-01)

Exploring the GLP-1–GLP-1R axis in porcine pancreas and gastrointestinal tract in vivo by ex vivo autoradiography
by: Jens Juul Holst, et al.
Published: (2021-03-01)

Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
by: Mohamed Altai, et al.
Published: (2018-10-01)

Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
by: Sara S. Rinne, et al.
Published: (2022-05-01)

Radiotracers for Imaging of Fibrosis: Advances during the Last Two Decades and Future Directions
by: Olof Eriksson, et al.
Published: (2023-11-01)

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
by: Ali Alhuseinalkhudhur, et al.
Published: (2020-03-01)

Regional distribution of mechanical strain and macrophage-associated lung inflammation after ventilator-induced lung injury: an experimental study
by: Francesco Liggieri, et al.
Published: (2024-09-01)

The Impact of Glycerol on an Affibody Conformation and Its Correlation to Chemical Degradation
by: Ingrid Ramm, et al.
Published: (2021-11-01)

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.
by: Magdalena Malm, et al.
Published: (2013-01-01)

Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
by: Maryam Oroujeni, et al.
Published: (2018-09-01)

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
by: Allal Boutajangout, et al.
Published: (2019-03-01)

Electrophilic affibodies forming covalent bonds to protein targets.
by: Holm, L, et al.
Published: (2009)

Engineering Saccharomyces cerevisiae for the production and secretion of Affibody molecules
by: Veronica Gast, et al.
Published: (2022-03-01)

[<sup>18</sup>F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44
by: Pierre Cheung, et al.
Published: (2023-02-01)

Recombinant amyloid beta-peptide production by coexpression with an affibody ligand
by: Dobson Christopher M, et al.
Published: (2008-10-01)

Designing, docking and heterologous expression of an anti-HER2 affibody molecule
by: N. Salmanian Tabasi, et al.
Published: (2018-02-01)

Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules
by: Javad Garousi, et al.
Published: (2020-06-01)

Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.
by: Kristian Sexton, et al.
Published: (2013-01-01)

Toxicology and Biodistribution: The Clinical Value of Animal Biodistribution Studies
by: Beatriz Silva Lima, et al.
Published: (2018-03-01)

Stability Enhancement of a Dimeric HER2-Specific Affibody Molecule through Sortase A-Catalyzed Head-to-Tail Cyclization
by: Kristina Westerlund, et al.
Published: (2021-05-01)

Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts.
by: Joanna Strand, et al.
Published: (2013-01-01)

Improved Radiolytic Stability of a <sup>68</sup>Ga-labelled Collagelin Analogue for the Imaging of Fibrosis
by: Irina Velikyan, et al.
Published: (2021-09-01)

The Use of a Non-Conventional Long-Lived Gallium Radioisotope <sup>66</sup>Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule
by: Maryam Oroujeni, et al.
Published: (2021-02-01)

Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma
by: Saidu Kamara, et al.
Published: (2024-11-01)

EGFR-antagonistic affibody-functionalized Pt-based nanozyme for enhanced tumor radiotherapy
by: Haijun Wang, et al.
Published: (2023-06-01)

Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
by: Abida Zahirović, et al.
Published: (2022-07-01)